No. Delta-9 THC remains a Class B controlled substance under the Misuse of Drugs Act 1971, with possession punishable by up to 5 years’ imprisonment. Exemptions exist only for licensed medicinal products approved by the Medicines and Healthcare products Regulatory Agency (MHRA), such as Epidyolex for epilepsy. The 2026 Home Office review of cannabis scheduling is unlikely to reclassify Delta-9 THC without stringent pharmaceutical-grade standards.
Key Regulations for Delta 9 THC in United Kingdom
- Misuse of Drugs Act 1971: Class B status applies to all Delta-9 THC forms, including hemp-derived extracts exceeding 0.2% THC, unless exempt under medicinal licensing.
- MHRA Licensing: Only cannabis-based medicinal products (CBMPs) with MHRA approval may be prescribed; unlicensed products, even if low-THC, violate the Human Medicines Regulations 2012.
- Border Controls: The UK Border Force enforces THC limits for travelers, seizing products exceeding 0.2% THC under the Psychoactive Substances Act 2016, irrespective of origin.